Download App
Help CenterSubscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

ANG Lifesciences India Ltd (540694)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540694 NSE: Pharmaceuticals & Drugs | Small Cap | ANG Lifesciences Share Price

₹35.92 0.12 (0.34%)

As on 11-Sep'26 16:59

ANG Lifesciences India Ltd (540694)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540694 NSE: Pharmaceuticals & Drugs | Small Cap | ANG Lifesciences Share Price

₹35.92 0.12 (0.34%)

As on 11-Sep'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹47 Cr.
Current Price
₹35.9
52-Week Low / High
₹18 / 50
TTM EPS
₹-10.2
TTM Sales
₹83.6 Cr.
Book Value per Share
₹37.3
P/E Ratio
0.00
Industry PE
54.2
Price to Book (P/B)
0.96
In line with its 5-year historical median
Price to Sales (P/S)
0.56
Higher than its 5-year historical median
EV/EBITDA
-90.78
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
-17.70%
Underperforms industry median
Return on Capital Employed (ROCE)
-4.45%
Underperforms industry median
Return on Assets (ROA)
-5.38%
Operating Profit Margin
-1.6%
Net Profit Margin
-13.37%
Gross Profit Margin
-9.6%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
-31.56%
Operating Profit Growth (1 Year)
-
-118.91%
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
70.60%
Pledged shares (%) of Promoter's holding (%)
44.88%
Reserves
₹36 Cr.
Equity
₹13.1 Cr.
Face Value
₹10
All Time Low / High
₹10.62 / 640.36

ANG Lifesciences India stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is ANG Lifesciences India Ltd a good quality company?
ANG Lifesciences India Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does ANG Lifesciences India Ltd performance compare with that of its Peers?
Q.1 Revenue growth of ANG Lifesciences India Ltd vs industry peers?
ANG Lifesciences India Ltd revenue CAGR is -36.01%, compared to the industry median CAGR of 0.00%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of ANG Lifesciences India Ltd?
Promoters hold 70.60% of the ANG Lifesciences India Ltd, with 44.88% of their stake pledged, indicating high pledge risk.
Q.1 Stock return of ANG Lifesciences India Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -33.25% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
ANG Lifesciences India Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ23.4%29.7%22.2%23.7%22.4%19.9%53.8%9.2%0.7%-4%-
Value Creation
Index ⓘ		0.71.10.60.70.60.42.8-0.3-1.0-1.3-

Growth Parameters ⓘ
Sales ⓘ54.967.77612212715434920713189.981
Sales YoY Gr.-23.2%12.4%60.1%4.2%21.6%126%-40.6%-36.5%-31.6%-
Adj EPS ⓘ1.83.12.94.54.95.630.7-0.3-5.7-7.7-5.6
YoY Gr.-70.6%-6.5%57.1%9.5%13.2%449.9%-100.9%NANA-
BVPS (₹) ⓘ5.28.117.922.226.731.964.465.55951.245
Adj Net
Profit ⓘ		1.72.83.75.86.47.339.8-0.4-7.5-10-7
Cash Flow from Ops. ⓘ1.94.50.97.54.8-11.227.426-13.1-2.3-
Debt/CF from Ops. ⓘ7.3321.22.94.3-3.82.22-4.3-29.6-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ5.6%-6.7%-36.4%-31.6%
Adj EPS ⓘ-217.5%-209.2%-163%NA
BVPSⓘ29%13.9%-7.4%-13.3%
Share Price - -33.9% -21.7% 4.7%

Key Financial Parameters ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		4246.124.322.520.219.163.8-0.4-9.2-13.9-11.7
Op. Profit
Mgn % ⓘ		8.6109.91010.49.918.95.97.4-1.14.1
Net Profit
Mgn % ⓘ		34.24.94.85.14.711.4-0.2-5.7-11.2-9.1
Debt to
Equity ⓘ		2.81.80.80.80.610.70.60.71-
Working Cap
Days ⓘ		139168198152180223155299439603274
Cash Conv.
Cycle ⓘ		142851567265369813320019

Valuation of ANG Lifesciences - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *44.8844.8844.8844.8844.8844.8844.8844.8844.8844.88
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales354.30219.89146.1192.85
Operating Expenses ⓘ + 286.41205.16136.0194.76
Manufacturing Costs16.1913.697.687.06
Material Costs227.98150.5995.1159.62
Employee Cost 21.2923.9719.3517.45
Other Costs ⓘ 20.9516.9013.8610.62
Operating Profit ⓘ 67.9014.7410.10-1.91
Operating Profit Margin (%) 19.2%6.7%6.9%-2.1%
Other Income ⓘ + 0.909.720.702.21
Exceptional Items ⓘ 00-1.740
Interest ⓘ 9.4212.4811.419.25
Depreciation ⓘ 5.889.358.376.76
Profit Before Tax ⓘ 53.502.63-10.71-15.70
Tax ⓘ 13.182.89-0.57-3.29
Profit After Tax 40.32-0.26-10.14-12.41
PAT Margin (%) 11.4%-0.1%-6.9%-13.4%
Adjusted EPS (₹)31.1-0.2-7.8-9.5
Dividend Payout Ratio (%)2.60%0%0%0%
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 83.7786.2276.2863.98
Share Capital ⓘ 10.3713.0613.0613.06
Reserves ⓘ 73.4073.1663.2250.92
Debt +68.2263.4264.2774.74
Long Term Debt21.6418.4913.9518.86
Short Term Debt46.5844.9350.3355.88
Minority Interest0000
Trade Payables70.6368.1966.1866.07
Others Liabilities ⓘ 64.1355.7231.2518.43
Total Liabilities ⓘ 286.75273.54237.98223.22

Fixed Assets

Net Fixed Assets ⓘ +92.6188.1558.4057.19
Gross Block141.97146.86120.52126.07
Accumulated Depreciation49.3658.7162.1268.88
CWIP ⓘ 0000
Investments ⓘ 0.030.030.030.03
Inventories36.9648.4947.7754.11
Trade Receivables102.0683.1573.2866.54
Cash Equivalents 6.656.185.743.64
Others Assets ⓘ 48.4447.5652.7841.72
Total Assets ⓘ 286.75273.54237.98223.22
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 24.7226.38-9.49-0.26
PBT ⓘ 53.502.63-10.71-15.70
Adjustment ⓘ 16.8020.7019.9013.45
Changes in Working Capital ⓘ -45.056.51-5.276.22
Tax Paid ⓘ -0.53-3.46-13.41-4.23
Cash Flow From Investing Activity ⓘ + -44.41-9.3319.89-1.59
Capex -41.34-10.4418.93-3.75
Net Investments -3.430.450.441.94
Others ⓘ 0.370.670.530.23
Cash Flow From Financing Activity ⓘ + 19.93-17.07-10.401.68
Net Proceeds from Shares ⓘ 0200
Net Proceeds from Borrowing ⓘ 11.41-5.36-4.095.63
Interest Paid ⓘ -7.96-11.75-10.64-8.37
Dividend Paid ⓘ -1.04000
Others ⓘ 17.51-1.964.334.43
Net Cash Flow ⓘ 0.23-0.02-0.01-0.16
PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)48.13-0.31-12.48-17.7
ROCE (%)39.149.590.46-4.45
Asset Turnover Ratio1.240.780.570.4
PAT to CFO Conversion(x)0.61N/AN/AN/A
Working Capital Days
Receivable Days105.10153.70195.40274.80
Inventory Days38.1070.90120.20200.30
Payable Days113.10168.20257.80404.80

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

ANG Lifesciences India Ltd FAQs

The current trading price of ANG Lifesciences on 11-Sep-2026 16:59 is ₹35.92.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Sep-2026 the market cap of ANG Lifesciences stood at ₹46.91 Cr

The latest P/E ratio of ANG Lifesciences as of 10-Sep-2026 is 0.00.

The latest P/B ratio of ANG Lifesciences as of 10-Sep-2026 is 0.80.

The 52-week high of ANG Lifesciences is ₹49.69 and the 52-week low is ₹17.63.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of ANG Lifesciences is ₹81.03 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that ANG Lifesciences India Ltd is a below average quality company.

The key valuation ratios of ANG Lifesciences India Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of ANG Lifesciences India Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About ANG Lifesciences India Ltd

No data to display
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now